Subsequent PPI network analysis and hub gene screening revealed four key candidates: BTG2 (downregulated), S100A6, SCARB1, and INHBA (all upregulated) in PE with GDM patients compared to controls. This evidence concerns the gene S100A6 and gestational diabetes.